BioCentury
ARTICLE | Company News

Evotec OAI AG, Lectus Therapeutics deal

August 9, 2004 7:00 AM UTC

EVT will apply its medicinal chemistry services to Lectus's next- generation ion channel modulators to treat disorders related to smooth muscle hyperreactivity, including bladder disorders, angina and...